Citation
Zhao, Li-Zi, et al. "Determination of Levonorgestrel in Human Plasma By Liquid Chromatography-tandem Mass Spectrometry Method: Application to a Bioequivalence Study of Two Formulations in Healthy Volunteers." Biomedical Chromatography : BMC, vol. 22, no. 5, 2008, pp. 519-26.
Zhao LZ, Zhong GP, Bi HC, et al. Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers. Biomed Chromatogr. 2008;22(5):519-26.
Zhao, L. Z., Zhong, G. P., Bi, H. C., Ding, L., Deng, Y., Guan, S., Chen, X., Huang, Z. Y., & Huang, M. (2008). Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers. Biomedical Chromatography : BMC, 22(5), 519-26. https://doi.org/10.1002/bmc.963
Zhao LZ, et al. Determination of Levonorgestrel in Human Plasma By Liquid Chromatography-tandem Mass Spectrometry Method: Application to a Bioequivalence Study of Two Formulations in Healthy Volunteers. Biomed Chromatogr. 2008;22(5):519-26. PubMed PMID: 18254150.
TY - JOUR
T1 - Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers.
AU - Zhao,Li-Zi,
AU - Zhong,Guo-Ping,
AU - Bi,Hui-Chang,
AU - Ding,Liang,
AU - Deng,Ying,
AU - Guan,Su,
AU - Chen,Xiao,
AU - Huang,Zhi-ying,
AU - Huang,Min,
PY - 2008/2/7/pubmed
PY - 2008/7/3/medline
PY - 2008/2/7/entrez
SP - 519
EP - 26
JF - Biomedical chromatography : BMC
JO - Biomed Chromatogr
VL - 22
IS - 5
N2 - A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC/MS/MS) method to determine levonorgestrel in human plasma was developed and fully validated. After hexane-ethyl acetate (70:30, v/v) induced extraction from the plasma samples, levonorgestrel was subjected to LC/MS/MS analysis using electro-spray ionization. The MS system was operated in the selected reaction monitoring mode. Chromatographic separation was performed on a Hypersil BDS C18 column (i.d. 2.1x50 mm, particle size 3 microm). The method had a chromatographic running time of 2.0 min and linear calibration curves over the concentration ranges of 0.25-90 ng/mL for levonorgestrel. The lower limit of quantification of the method was 0.25 ng/mL for levonorgestrel. The intra- and inter-batch precision was 3.7-10.2 and 5.1-12.9%, respectively, for all quality control samples at concentrations of 0.5, 6.0 and 45.0 ng/mL. These results indicate that the method was efficient with a simple preparation procedure and a very short running time (2.0 min) for levonorgestrel compared with those methods reported in the literature and had high selectivity, acceptable accuracy, precision and sensitivity. The validated LC/MS/MS method was successfully used for a bioequivalence study of two tablet formulations of levonorgestrel in healthy volunteers.
SN - 0269-3879
UR - https://www.unboundmedicine.com/medline/citation/18254150/Determination_of_levonorgestrel_in_human_plasma_by_liquid_chromatography_tandem_mass_spectrometry_method:_application_to_a_bioequivalence_study_of_two_formulations_in_healthy_volunteers_
L2 - https://doi.org/10.1002/bmc.963
DB - PRIME
DP - Unbound Medicine
ER -